Core C - The Administrative Core will serve to coordinate administrative interactions between the different projects, their leadership, and scientists within the PPG, in order to facilitate the successful accomplishment of the scientific goals. This Core will oversee the facilitation and organization of regular meetings of the Steering Committee (Project and Core Leaders). Agendas for these meetings will include review of progress on the overall goals of the PPG. The reviews will also include assessments of the logistics of all interactions between Projects and Cores in order to identify any potential bottlenecks in transfer of specimens, data, protocols, funds, or other items. The Project and Core Leaders will also review expenditures and allocations of resources for all Projects and Cores at least twice per year. Reports from the external and internal scientific advisory boards will be collated and reviewed by the Project and Core Leaders following each annual PPG annual review, which will occur during the annual retreat. The administrative core will oversee collection and collation of annual reports from all Project and Core Leaders and compiling it into the annual progress report to NIH. The PI of this PPG, along with the Program Administrator, will assure smooth operation of the scientific agenda of the program project. The Administrative Core will organize all aspects of the annual retreat, which will include Project and Core Leaders, Co-Leaders and their laboratory staffs, and Scientific Advisory Board Members. The Administrative Core will oversee the launch and maintenance of a Web page for this PPG will allow distribution of findings among the global community, while enabling sharing protocols, reagents as well as information among the projects in real time.

Agency
National Institute of Health (NIH)
Type
Research Program Projects (P01)
Project #
5P01CA163222-02
Application #
8736412
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Roider, Elisabeth M; Fisher, David E (2014) The impact of MITF on melanoma development: news from bench and bedside. J Invest Dermatol 134:16-7
Konieczkowski, David J; Johannessen, Cory M; Abudayyeh, Omar et al. (2014) A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov 4:816-27
Van Allen, Eliezer M; Wagle, Nikhil; Sucker, Antje et al. (2014) The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov 4:94-109
Lo, Jennifer A; Fisher, David E (2014) The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science 346:945-9
Wagle, Nikhil; Van Allen, Eliezer M; Treacy, Daniel J et al. (2014) MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition. Cancer Discov 4:61-8
Sullivan, Ryan J; Fisher, David E (2014) Understanding the biology of melanoma and therapeutic implications. Hematol Oncol Clin North Am 28:437-53
Pop, Marius S; Stransky, Nicolas; Garvie, Colin W et al. (2014) A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein. Mol Cancer Ther 13:1492-502
Chen, Hongxiang; Weng, Qing Y; Fisher, David E (2014) UV signaling pathways within the skin. J Invest Dermatol 134:2080-5
Fell, Gillian L; Robinson, Kathleen C; Mao, Jianren et al. (2014) Skin ?-endorphin mediates addiction to UV light. Cell 157:1527-34
Hsiao, Jennifer J; Fisher, David E (2014) The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys 563:28-34

Showing the most recent 10 out of 12 publications